このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

症例報告: 進行した腎臓状細胞癌と肺転移の患者における化学放射線療法と免疫療法の統合

  • 0Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

|

|

まとめ

この要約は機械生成です。

腎臓状細胞癌 (RSCC) は希少で攻撃的である. 化学放射線療法と免疫療法の組み合わせにより,転移した進行RSCC患者で寛解が達成され,手術不可能な症例への希望が示されました.

科学分野

  • 腫瘍学
  • 泌尿腫瘍学

背景

  • 腎臓状細胞癌 (RSCC) は,予後が悪い珍しい腎臓悪性腫瘍である.
  • 進行したRSCCの治療ガイドラインは,特に手術不可能なケースは,十分に確立されていません.

関連する概念動画

Tumor Immunotherapy 01:27

660

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies 02:49

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers 02:56

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Combination Therapies and Personalized Medicine 02:50

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...